A detailed history of Nuveen Asset Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 182,485 shares of LQDA stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
182,485
Previous 182,485 -0.0%
Holding current value
$2.11 Million
Previous $2.19 Million 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$11.96 - $15.71 $341,709 - $448,850
28,571 Added 18.56%
182,485 $2.19 Million
Q4 2023

Feb 14, 2024

BUY
$5.77 - $12.19 $12,076 - $25,513
2,093 Added 1.38%
153,914 $1.85 Million
Q3 2023

Nov 14, 2023

SELL
$6.27 - $8.15 $6,188 - $8,044
-987 Reduced 0.65%
151,821 $962,000
Q1 2023

May 15, 2023

SELL
$5.72 - $7.91 $260,231 - $359,865
-45,495 Reduced 22.94%
152,808 $1.06 Million
Q4 2022

Feb 14, 2023

SELL
$4.68 - $6.54 $290,347 - $405,741
-62,040 Reduced 23.83%
198,303 $1.26 Million
Q3 2022

Nov 14, 2022

SELL
$3.73 - $8.39 $19,589 - $44,064
-5,252 Reduced 1.98%
260,343 $1.42 Million
Q2 2022

Aug 15, 2022

BUY
$3.37 - $7.55 $895,055 - $2.01 Million
265,595 New
265,595 $1.16 Million
Q2 2021

Aug 16, 2021

SELL
$2.51 - $3.11 $272,199 - $337,267
-108,446 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$2.42 - $3.6 $37,079 - $55,159
15,322 Added 16.45%
108,446 $292,000
Q4 2020

Feb 16, 2021

SELL
$2.6 - $5.79 $9,302 - $20,716
-3,578 Reduced 3.7%
93,124 $274,000
Q3 2020

Nov 16, 2020

BUY
$4.34 - $8.28 $55,586 - $106,050
12,808 Added 15.27%
96,702 $475,000
Q2 2020

Aug 14, 2020

BUY
$4.86 - $11.44 $237,892 - $559,976
48,949 Added 140.07%
83,894 $706,000
Q1 2020

May 14, 2020

BUY
$3.31 - $7.15 $76 - $164
23 Added 0.07%
34,945 $164,000
Q4 2019

Feb 14, 2020

SELL
$3.07 - $5.11 $3,530 - $5,876
-1,150 Reduced 3.19%
34,922 $149,000
Q2 2019

Aug 15, 2019

BUY
$7.92 - $11.39 $285,690 - $410,860
36,072 New
36,072 $289,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $743M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.